Guoxian Wu
The First People's Hospital of Xiaoshan District, Hangzhou(CN)Plexxikon (United States)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment, Melanoma and MAPK Pathways, Advanced Chemical Physics Studies, MicroRNA in disease regulation
Most-Cited Works
- → RAF inhibitors that evade paradoxical MAPK pathway activation(2015)376 cited
- → Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor(2013)95 cited
- → Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors(2021)39 cited
- → Circ-RNF111 aggravates the malignancy of gastric cancer through miR-876-3p-dependent regulation of KLF12(2021)19 cited
- → PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors(2018)18 cited
- → A Laser Flash Photolysis Study of Dibromocarbene and Bromochlorocarbene(1998)9 cited
- → Abstract A229: BRAF inhibitors upregulate EGFR ligands: A molecular link to RAF inhibitor-induced cutaneous squamous cell carcinomas.(2011)1 cited